DrugPatentWatch Database Preview
Drugs in MeSH Category Chelating Agents
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Msn Labs Pvt Ltd | TRIENTINE HYDROCHLORIDE | trientine hydrochloride | CAPSULE;ORAL | 211134-001 | May 22, 2019 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Navinta Llc | TRIENTINE HYDROCHLORIDE | trientine hydrochloride | CAPSULE;ORAL | 211251-001 | Jan 16, 2019 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Valeant Pharms Intl | CUPRIMINE | penicillamine | CAPSULE;ORAL | 019853-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
